Literature DB >> 1067623

Evidence for and against the involvement of N,N-dimethyl-tryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in schizophrenia.

J C Gillin, R J Wyatt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1067623

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  3 in total

Review 1.  Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

Authors:  Hong-Wu Shen; Xi-Ling Jiang; Jerrold C Winter; Ai-Ming Yu
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

Review 2.  Neuropharmacology of N,N-dimethyltryptamine.

Authors:  Theresa M Carbonaro; Michael B Gatch
Journal:  Brain Res Bull       Date:  2016-04-25       Impact factor: 4.077

3.  Pursuit of the "truth" about mental illness: the significance of findings in neuropsychiatric research, and lessons from the past.

Authors:  Lynn E DeLisi
Journal:  Dialogues Clin Neurosci       Date:  2014-12       Impact factor: 5.986
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.